TOP STORIES

• REGULATORY Govt to Support Shift to 24-Hour Production for Cough Drugs: Minister
  November 8, 2023

• BUSINESS Eisai CEO Confident of Achieving Leqembi Sales Goal of 10 Billion Yen in FY2023
  November 8, 2023

• BUSINESS Air Pollutant Might Be to Blame for NDMA Formation in Metformin: Towa Paper
  November 7, 2023

• BUSINESS Chugai Offloading Xeloda to Cheplapharm after German Firm Plants Flag in Japan
  November 7, 2023

• REGULATORY Health Minister to Make Direct Request to 24 Makers for Supply Ramp-Up
  November 7, 2023

• REGULATORY Japan PM Advisor Pushes Rethink of LLP Coverage to Reward Innovation, Pricing Debate without Taboos
  November 6, 2023

• REGULATORY Japan OKs New Economic Package; Startup, Pharma Promotion Embraced
  November 6, 2023

• REGULATORY Reward Innovation by Revisiting LLP Copay, Cut Doctor Fees: MOF
  November 2, 2023

• BUSINESS Sumitomo Eyes Return to Core Operating Profit in FY2024, Pruning Roivant Shares
  November 1, 2023

• BUSINESS 301 Employees Apply for Shionogi’s Voluntary Buyout Program
  November 1, 2023

• BUSINESS VLP Therapeutics Eyes Japan Filing of Next-Gen mRNA Vaccine in Mid-2024: CEO
  October 31, 2023

• REGULATORY No Objections to Reflecting Company Indices for Generic Supplies in Pricing: Chuikyo
  October 30, 2023

• REGULATORY Medical, Long-Term Care Data Linkage Holds Key to CEA: Leqembi Debate
  October 30, 2023

• BUSINESS Merck Sues Sawai over Januvia Generics Approved in Japan
  October 27, 2023

• ORGANIZATION Chuikyo Rep Interview 3-2 - Rengo Wants Substantive Discussions on Pricing System, Off-Year Revisions over Next Few Years
  October 26, 2023

• BUSINESS With Wholesalers Narrowed Down, Hospitals Face Squeezed Discounts for GSK Products
  October 25, 2023

• ORGANIZATION Chuikyo Rep Interview 3-1 - Rengo Seeks Patient-Centric Debate, Sees Exhausted Wholesalers as Big Issue
  October 25, 2023

• BUSINESS Sawai Fudged Quality Tests of Gastritis Drug for 8 Years, Awaiting Penalty Decision
  October 24, 2023

• BUSINESS Daiichi Sankyo, Merck in Global ADC Deal Worth Up to US$22 Billion
  October 23, 2023

• REGULATORY Chuikyo Wants Sakigake Premium Review as a Package with Regulatory Reform
  October 23, 2023

ページ

• « 先頭
• ‹ Prev
• …
• 51
• 52
• 53
• 54
• 55
• 56
• 57
• 58
• 59
• …
• Next ›
• 最終 »